000			01421 a2200385 4500
005			20250513225258.0
264		0	_c20010705
008			200107s 0 0 eng d
022			_a1523-3804
024	7		_a10.1007/s11883-000-0061-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaron, D J
245	0	0	_aPercutaneous coronary intervention versus medical therapy for coronary heart disease. _h[electronic resource]
260			_bCurrent atherosclerosis reports _cJul 2000
300			_a290-6 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Review
650	0	4	_aAdrenergic beta-Antagonists _xtherapeutic use
650	0	4	_aAngioplasty, Balloon, Coronary
650	0	4	_aAnticholesteremic Agents _xtherapeutic use
650	0	4	_aAtorvastatin
650	0	4	_aCalcium Channel Blockers _xtherapeutic use
650	0	4	_aCholesterol, LDL _xmetabolism
650	0	4	_aCoronary Disease _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHeptanoic Acids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aNitrates _xtherapeutic use
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
773	0		_tCurrent atherosclerosis reports _gvol. 2 _gno. 4 _gp. 290-6
856	4	0	_uhttps://doi.org/10.1007/s11883-000-0061-9 _zAvailable from publisher's website
999			_c11063255 _d11063255